Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis

Abstract

Nitroprusside rapidly and markedly improves cardiac function in patients with decompensated heart failure due to severe left ventricular systolic dysfunction and severe aortic stenosis. It provides a safe and effective bridge to aortic-valve replacement or oral vasodilator therapy in these critically ill patients.